Proteovista LLC is categorized under Research and Development Laboratories in Madison, WI and active since 2009.
Proteovista LLC was established in 2009, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Mary S Ozers at the company’s single location by writing to 510 Charmany Drive # 57, Madison, Wisconsin WI 53719 or by phoning (608) 441-2824. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Proteovista LLC |
| Contact Person: | Mary S Ozers |
| Address: | 510 Charmany Drive # 57, Madison, Wisconsin 53719 |
| Phone Number: | (608) 441-2824 |
| Website Address: | proteovista.com |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Proteovista LLC was started in 2009 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Mary S Ozers for inquiries that concern Proteovista LLC by calling the company number (608) 441-2824, as your correspondence is most welcome. Additionally, the physical location of the single location of Proteovista LLC can be found at the coordinates 43.058636,-89.475607 as well as the street address 510 Charmany Drive # 57 in Madison, Wisconsin 53719.
For its online presence, you may visit Proteovista LLC’s website at proteovista.com and engage with its social media outlets through on Twitter and on Facebook.